Tarsus Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (TARS)

45 filings reported holding TARS - Tarsus Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share as of Q4 2021.
Tarsus Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (TARS) has 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 13.1M shares of 42.2M outstanding shares and own 30.96% of the company stock.
Largest 10 shareholders include Vivo Capital, LLC (2.99M shares), RTW INVESTMENTS, LP (2.01M shares), FRAZIER MANAGEMENT LLC (1.42M shares), Cormorant Asset Management, LP (1.4M shares), PERCEPTIVE ADVISORS LLC (1.3M shares), TimesSquare Capital Management, LLC (661K shares), COWEN AND COMPANY, LLC (514K shares), VANGUARD GROUP INC (459K shares), BlackRock Inc. (449K shares), and Jefferies Group LLC (423K shares).
This table shows the top 42 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.